ArticleViruses2022

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine.

Dong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.